Parkside Investments LLC Sells 454 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Parkside Investments LLC reduced its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 43,890 shares of the pharmacy operator’s stock after selling 454 shares during the quarter. Parkside Investments LLC’s holdings in Walgreens Boots Alliance were worth $2,400,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. Comerica Securities Inc. raised its holdings in shares of Walgreens Boots Alliance by 23.7% during the fourth quarter. Comerica Securities Inc. now owns 16,457 shares of the pharmacy operator’s stock worth $1,124,000 after acquiring an additional 3,154 shares during the period. Geode Capital Management LLC increased its stake in Walgreens Boots Alliance by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock valued at $786,522,000 after buying an additional 834,241 shares during the last quarter. Hills Bank & Trust Co. increased its stake in Walgreens Boots Alliance by 5.5% in the 1st quarter. Hills Bank & Trust Co. now owns 3,815 shares of the pharmacy operator’s stock valued at $242,000 after buying an additional 200 shares during the last quarter. City Holding Co. increased its stake in Walgreens Boots Alliance by 1.1% in the 1st quarter. City Holding Co. now owns 31,228 shares of the pharmacy operator’s stock valued at $1,976,000 after buying an additional 342 shares during the last quarter. Finally, IFM Investors Pty Ltd grew its position in shares of Walgreens Boots Alliance by 6.8% in the 1st quarter. IFM Investors Pty Ltd now owns 51,937 shares of the pharmacy operator’s stock valued at $3,286,000 after acquiring an additional 3,304 shares during the period. 61.97% of the stock is currently owned by institutional investors.

A number of research analysts have recently commented on the stock. Morgan Stanley set a $61.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Tuesday, May 14th. Bank of America decreased their price objective on shares of Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research report on Monday, June 3rd. JPMorgan Chase & Co. decreased their price objective on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, June 28th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Finally, Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective for the company. in a research report on Monday, June 10th. Six equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $63.82.



Walgreens Boots Alliance stock traded up $1.27 during midday trading on Friday, hitting $50.56. The company’s stock had a trading volume of 174,888 shares, compared to its average volume of 4,470,581. Walgreens Boots Alliance Inc has a 1-year low of $49.12 and a 1-year high of $86.31. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The company has a 50-day moving average price of $54.27 and a two-hundred day moving average price of $57.61. The company has a market cap of $47.93 billion, a price-to-earnings ratio of 8.41, a PEG ratio of 1.33 and a beta of 0.81.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.05. The business had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The business’s revenue was up .7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.53 EPS. Sell-side analysts forecast that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be given a $0.458 dividend. The ex-dividend date is Monday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a dividend yield of 3.62%. Walgreens Boots Alliance’s payout ratio is presently 29.24%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Using the New Google Finance Tool

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.